Form 4: COSM CEO Boosts Stake via Debt-for-Equity Swap

Cosmos Health Inc. CEO Grigorios Siokas increased his beneficial ownership by acquiring 90,325 shares of common stock through a debt exchange agreement.

Summary

• Grigorios Siokas, CEO, Director, and 10% Owner of Cosmos Health Inc. (COSM), acquired 90,325 shares of common stock.
• The acquisition occurred on January 23, 2026, at an exchange rate of $0.4982 per share.
• This transaction was part of a debt exchange agreement, settling $45,000 in debt owed by the company to Mr. Siokas.
• Following this transaction, Mr. Siokas directly beneficially owns 8,182,120 shares of Cosmos Health Inc. common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The insider purchase by the CEO, Director, and 10% owner is a positive signal of confidence. While the debt conversion suggests the company owed money to the CEO, settling it with equity at fair market value is a reasonable approach, and the overall sentiment leans positive due to the insider's increased stake.

Positives

• Insider buying by the CEO, Director, and 10% owner, Grigorios Siokas, signals confidence in the company's future.
• The company reduced its outstanding debt by $45,000 through a non-cash transaction.
• The transaction was executed at the fair market value of the common stock on the transaction date, $0.4982 per share.

Negatives

• The company owed $45,000 to its CEO, which could indicate liquidity management considerations.
• The issuance of new shares, even for debt conversion, results in minor dilution for existing shareholders.

Risks

• The company's reliance on debt conversion to settle obligations to its CEO could suggest underlying cash flow challenges.
• Future debt conversions or equity issuances could lead to further dilution.

Future Outlook

Not applicable as this filing is a disclosure of an insider transaction and does not contain forward-looking statements or guidance.

Industry Context

Insider purchases, especially by a CEO and significant owner, are often viewed by the market as a positive signal, indicating management's belief in the company's future prospects. This transaction also highlights a common method for companies to manage debt obligations by converting them into equity, particularly when cash flow might be prioritized for other operational needs.

Comparison to Industry Standards

• Insider buying by a CEO is generally seen as a strong vote of confidence, aligning management's interests with shareholders.
• While the debt conversion mechanism is not uncommon, the specific valuation of $0.4982 per share reflects the fair market value at the time of the transaction, which is standard practice for such exchanges.
• Without specific comparable transactions from other health or pharmaceutical companies, it is difficult to benchmark the terms of this particular debt exchange, but the act of an insider increasing their stake is broadly positive.

Related Party Transactions

• Grigorios Siokas, the Company's CEO, Director, and 10% owner, acquired 90,325 shares of common stock from the company in exchange for $45,000 of debt the company owed to him, pursuant to a Debt Exchange Agreement dated January 23, 2026.

Stakeholder Impact

• Shareholders: Potential minor dilution from the issuance of new shares, but also a positive signal of insider confidence.
• Creditors (specifically Grigorios Siokas): Debt owed to the CEO has been settled through equity, converting a creditor position into an equity holder position.
• Company: Reduced debt on its balance sheet by $45,000 without expending cash.

Key Dates

Keywords

Cosmos Health Inc., COSM, Grigorios Siokas, Insider Trading, Form 4, Debt Exchange, Equity Acquisition, CEO Stock Purchase, Shareholder Ownership, Rule 10b5-1